Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-104121
Filing Date
2026-03-12
Accepted
2026-03-12 16:07:20
Documents
82
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bolt-20251231.htm   iXBRL 10-K 3524444
2 EX-21.1 bolt-ex21_1.htm EX-21.1 5106
3 EX-23.1 bolt-ex23_1.htm EX-23.1 3527
4 EX-31.1 bolt-ex31_1.htm EX-31.1 14893
5 EX-32.1 bolt-ex32_1.htm EX-32.1 7942
  Complete submission text file 0001193125-26-104121.txt   13575346

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20251231.xsd EX-101.SCH 1513312
84 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20251231_htm.xml XML 2804388
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39988 | Film No.: 26747690
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)